BIO-RAD LABORATORIES, INC. (BIO) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Bio Rad Laboratories, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was $44.7 M, a 27.8% decline year-over-year.
  • Bio Rad Laboratories, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was $321 M, a 19.5% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2023 was $338 M, a 30% decline from 2022.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2022 was $483 M, a 3.54% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Operating Income (Loss) for 2021 was $500 M, a 18.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $321 M $44.7 M -$17.2 M -27.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $338 M $95.3 M -$23.4 M -19.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $361 M $90.9 M -$3.7 M -3.91% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $365 M $89.6 M -$33.3 M -27.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $398 M $61.9 M -$84.5 M -57.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $483 M $119 M +$782 K +0.66% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $482 M $94.6 M -$62.2 M -39.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $544 M $123 M -$1.89 M -1.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $546 M $146 M +$45.5 M +45.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $500 M $118 M -$67.7 M -36.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $568 M $157 M +$47.2 M +43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $521 M $125 M +$73 M +141% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $448 M $101 M +$26.5 M +35.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $421 M $186 M +$126 M +214% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $295 M $110 M +$52.1 M +90.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $243 M $51.7 M -$4.65 M -8.24% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $247 M $74.4 M +$17.8 M +31.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $230 M $59.2 M +$286 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 -$56.6 M $57.5 M +$21.2 M +58.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$77.8 M $56.4 M +$12.6 M +28.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 -$90.4 M $56.6 M +$13 M +29.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$103 M -$227 M -$273 M -595% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $170 M $36.3 M -$2.49 M -6.42% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $172 M $43.8 M +$45.5 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $127 M $43.6 M +$17.4 M +66.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $109 M $45.9 M +$74.1 M Oct 1, 2017 Dec 31, 2017 10-K 2018-04-16
Q3 2017 $35.1 M $38.8 M +$16.1 M +70.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $19 M -$1.7 M -$28.6 M -106% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $47.6 M $26.2 M +$6.01 M +29.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $41.6 M -$28.2 M -$87.7 M -147% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $129 M $22.7 M -$9.97 M -30.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-16
Q2 2016 $139 M $26.9 M -$13.3 M -33.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-16
Q1 2016 $153 M $20.2 M -$14.1 M -41.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-16
Q4 2015 $167 M $59.5 M +$8.9 M +17.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-16
Q3 2015 $158 M $32.7 M -$569 K -1.71% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $158 M $40.2 M -$5.48 M -12% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $164 M $34.3 M +$13.9 M +67.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $150 M $50.6 M -$1.73 M -3.31% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $152 M $33.2 M +$4.18 M +14.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $148 M $45.7 M -$7.24 M -13.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $155 M $20.5 M -$14.7 M -41.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $169 M $52.3 M -$18.3 M -26% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $188 M $29.1 M -$36.8 M -55.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $225 M $52.9 M -$20.4 M -27.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $245 M $35.2 M -$19.2 M -35.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $264 M $70.7 M -$25.4 M -26.4% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $290 M $65.8 M -$8.08 M -10.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $298 M $73.3 M +$5.12 M +7.51% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $292 M $54.4 M -$12.8 M -19% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $305 M $96 M +$18.2 M +23.4% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-18
Q3 2011 $287 M $73.9 M -$880 K -1.18% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $288 M $68.2 M +$10 K +0.02% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $288 M $67.1 M +$3.87 M +6.12% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $284 M $77.8 M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-18
Q3 2010 $74.8 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $68.2 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $63.2 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.